How have YSBPW shares performed in 2024?

YS Biopharma's stock was trading at $0.0380 at the beginning of 2024. Since then, YSBPW stock has increased by 136.3% and is now trading at $0.0898. View the best growth stocks for 2024 here .

Are investors shorting YS Biopharma?

YS Biopharma saw a drop in short interest in March. As of March 31st, there was short interest totaling 11,600 shares, a drop of 45.0% from the March 15th total of 21,100 shares. Based on an average trading volume of 43,300 shares, the short-interest ratio is currently 0.3 days. View YS Biopharma's Short Interest .

How do I buy shares of YS Biopharma?

Shares of YSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:YSBPW

YS Biopharma (YSBPW) Stock Price, News & Analysis

→ FW: 234x Gain (From Weiss Ratings) (Ad)

Free YSBPW Stock Alerts

$0.09

+0.01 (+12.53%)

(As of 05/3/2024 ET)

Compare

Today's Range: $0.05
▼
$0.09
50-Day Range: $0.04
▼
$0.09
52-Week Range: $0.01
▼
$0.10

Volume: 500 shs
Average Volume: 41,585 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Social Media

Get YS Biopharma alerts:

Ad Colonial Metals

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

About YS Biopharma

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YSBPW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

YSBPW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive YSBPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:YSBPW
CUSIP: N/A
CIK: 1946399
Web: www.yishengbio.com
Phone: 86-10-8920-2086
Fax: N/A
Employees: 865
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $560.76 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Hui Shao (Age 54)
Pres, CEO & Exec. Director
Ms. Chunyuan Wu (Age 45)
Chief Financial Officer
Mr. Gang Li (Age 41)
Head of Marketing & Sales
Dr. Zenaida Reynoso Mojares (Age 64)
Chief Medical Officer
Dr. Yuan Liu (Age 36)
Head of Vaccine Research

Key Competitors

View All Competitors

YSBPW Stock Analysis - Frequently Asked Questions

How have YSBPW shares performed in 2024?: YS Biopharma's stock was trading at $0.0380 at the beginning of 2024. Since then, YSBPW stock has increased by 136.3% and is now trading at $0.0898.
View the best growth stocks for 2024 here.
Are investors shorting YS Biopharma?: YS Biopharma saw a drop in short interest in March. As of March 31st, there was short interest totaling 11,600 shares, a drop of 45.0% from the March 15th total of 21,100 shares. Based on an average trading volume of 43,300 shares, the short-interest ratio is currently 0.3 days.
View YS Biopharma's Short Interest.
How do I buy shares of YS Biopharma?: Shares of YSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YSBPW) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial